Clinical Trial Update: Bladder PREserVation by RadioTherapy and Immunotherapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating bladder preservation using radiotherapy and immunotherapy in patients with BCG-unresponsive non-muscle-invasive bladder cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Non-muscle-invasive Bladder Cancer | Phase 2 | Status: UNKNOWN